Mounjaro and Emotional Blunting: A Growing Concern with Weight-Loss Drugs
The rising popularity of weight-loss drugs like Mounjaro (tirzepatide) is bringing both success stories and previously unacknowledged side effects to light. While heralded as “miracle” drugs for their efficacy in promoting weight loss, some users are reporting a concerning emotional side effect: emotional blunting, or a diminished capacity to experience the full range of feelings.
Mounjaro’s Rapid Rise in India
Mounjaro, manufactured by Eli Lilly and Company, has quickly become India’s top-selling drug by value, surpassing even established medications like GSK’s Augmentin 1. Launched in March 2025, it generated 3.33 billion rupees in revenue by the end of October 2025, significantly outpacing its competitor, Novo Nordisk’s Wegovy 1. This surge in demand reflects a growing trend in India, where the anti-obesity drug market has experienced a sixfold increase in the past five years 2.
How Mounjaro Works
Mounjaro is a GLP-1 receptor agonist, a class of drugs originally developed to treat Type 2 diabetes. These medications mimic hormones that regulate appetite and blood sugar, leading to increased feelings of fullness and reduced food intake 1. Specifically, tirzepatide, the active ingredient in Mounjaro, acts on both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors 1.
The Unexpected Side Effect: Emotional Numbing
While effective for weight loss, some individuals are reporting a significant, and often overlooked, side effect: emotional blunting. One man shared his experience in a YouTube video, detailing how Mounjaro helped him lose 10 kilograms in three months, but as well diminished his emotional responses 3. He described a flattening of emotions, where joy, sadness, and even excitement felt muted. He likened it to someone “turning off the knob” on his feelings 3.
This emotional impact extended to his personal and professional life, diminishing his ability to find satisfaction in achievements. He noted that his urge to consume alcohol also disappeared 3. After discontinuing the drug, he reported a return of his full emotional range.
Known and Emerging Risks
Eli Lilly acknowledges potential side effects of Mounjaro, including the risk of thyroid tumors (including cancer), hypoglycemia, allergic reactions, kidney problems, stomach issues, vision changes, and gallbladder problems 3. However, the emotional side effects are only beginning to be recognized and discussed. Some studies have also hinted at potential psychiatric adverse events, including suicidal thoughts, associated with GLP-1 agonists 3.
The Bigger Picture: Weight-Loss Drugs in India
The demand for weight-loss drugs in India is driven by a high prevalence of obesity and Type 2 diabetes, with the country having the world’s second-largest number of overweight adults and over 77 million people with Type 2 diabetes 2. However, experts caution that these medications should not be seen as a substitute for a healthy diet and lifestyle 2. Dr. Rahul Baxi, a Mumbai-based diabetologist, emphasizes the importance of addressing the underlying causes of weight gain and the potential for muscle loss if the drugs are used without exercise 2.
Disclaimer: This article is based on individual experiences and emerging trends around weight-loss medications like Mounjaro. Results can vary widely from person to person. Always consult a qualified healthcare professional before starting any weight-loss treatment.